| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/2001 | WO2000056360A3 Vaccine against antigens from bacteriae |
| 01/25/2001 | WO2000054839A3 Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses |
| 01/25/2001 | WO2000053219A3 Compositions and methods for treating cancer and hyperproliferative disorders |
| 01/25/2001 | WO2000051633A3 MULTI-COMPONENT VACCINE COMPRISING AT LEAST THREE ANTIGENS TO PROTECT AGAINST DISEASE CAUSED BY $i(HAEMOPHILUS INFLUENZAE) |
| 01/25/2001 | DE19934029A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants |
| 01/25/2001 | DE19930959A1 Neue Antimycotika und Fungizide, Verfahren zu deren Herstellung und Verwendung New antimycotics and fungicides, processes for their preparation and use |
| 01/25/2001 | CA2381961A1 Splice variants of cd40-receptor |
| 01/25/2001 | CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | CA2379968A1 Gtp-binding protein associated factors |
| 01/25/2001 | CA2379852A1 Method for down-regulating gdf-8 activity |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379129A1 Fima pilus-based vaccines |
| 01/25/2001 | CA2379069A1 Fimh adhesin-based vaccines |
| 01/25/2001 | CA2378946A1 Psca: prostate stem cell antigen and uses thereof |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377247A1 Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2340721A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/24/2001 | EP1070255A1 Assay of igfbp complex |
| 01/24/2001 | EP1069910A1 Adjuvant compositions |
| 01/24/2001 | EP1069909A2 Conjugate vaccines for the prevention of dental caries |
| 01/24/2001 | EP1069908A2 Methods and modified cells for the treatment of cancer |
| 01/24/2001 | EP1069890A1 Incorporation of active substances in carrier matrixes |
| 01/24/2001 | EP0820471B1 Antibodies against heart muscle actin |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | EP0676964B1 Nitrosylation of enzyme sh groups as a therapeutic modality |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | CN1281468A Treatment with anti-ErbB2 antibodies |
| 01/24/2001 | CN1281371A Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| 01/24/2001 | CN1281366A Prevention and treatment of amyloidogenic disease |
| 01/24/2001 | CN1281336A Treatment of neoplasms with viruses |
| 01/24/2001 | CN1061098C Anti-microbial agents and screening method |
| 01/24/2001 | CN1060937C Use of cow mycobacteria for producing medicine for curing HIV infection patient |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177545 Antibody which preferentially binds an epitope of an enzymatic protein; for diagnosis of time events in tumor propagation and metastasis, autoimmune diseases, kidney defects and atherosclerotic injury |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177258 Amino acid sequences of protein; for screening enzyme inhibitors for use as parasiticides/insecticides; veterinary medicine |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177256 Antigen carbohydrate compounds and their use in immunotherapy |
| 01/23/2001 | US6177087 Administering a polymer conjugate |
| 01/23/2001 | US6177086 DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates |
| 01/23/2001 | US6177083 Immunology to gramnegative bacteria |
| 01/23/2001 | US6177082 Cold-adapted equine influenza viruses |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177080 Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/23/2001 | US6177077 TNT inhibitors for the treatment of neurological disorders |
| 01/23/2001 | US6177076 Method of treating bladder cancer with wild type vaccinia virus |
| 01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
| 01/23/2001 | CA2045323C Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide |
| 01/22/2001 | CA2313392A1 Agent for induction of antigen-specific t cell |
| 01/18/2001 | WO2001004349A2 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease |
| 01/18/2001 | WO2001004335A2 Human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | WO2001004333A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 01/18/2001 | WO2001004320A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | WO2001004319A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
| 01/18/2001 | WO2001004311A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2001 | WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004271A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004266A1 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 01/18/2001 | WO2001004160A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 01/18/2001 | WO2001004155A2 Feline interleukin-12 as an immune stimulant |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004150A2 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004143A2 Prostase vaccine |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001004138A1 Dsra protein and polynucleotides encoding the same |
| 01/18/2001 | WO2001003744A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 01/18/2001 | WO2001003734A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003730A1 Unmarked deletion mutants of mycobacteria and methods of using same |
| 01/18/2001 | WO2001003729A2 Recombinant envelope vaccine against flavivirus infection |
| 01/18/2001 | WO2001003727A1 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003717A2 Methods of inducing cell death |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000062803A3 ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS |
| 01/18/2001 | WO2000060050A3 Recombinant influenza viruses for vaccines and gene therapy |
| 01/18/2001 | WO2000057911A3 Hapten-conjugated mammalian cells and methods of making and using thereof |
| 01/18/2001 | WO2000057904A3 Attenuated dengue-3 virus vaccine |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000053774A3 Metalloproteinases and methods of use therefor |
| 01/18/2001 | WO2000051630A3 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | WO2000037634A3 Novel polypeptides and nucleic acids encoding same |
| 01/18/2001 | WO2000037067A3 Sensitizing agents for the treatment of skin lesions |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | DE19933089A1 Mittel zur Gewerbsregeneration Means for commercial regeneration |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |